Peer Exchange

Management of Cardiac Amyloidosis

EPISODE 1 : Cardiac Amyloidosis Diagnostic Workup

Key opinion leaders consider the diagnostic workup for differentiating patients referred with general amyloidosis.

EPISODE 2 : Hypertrophic Cardiomyopathy Historical Prognosis

A discussion on the historical prognosis of hypertrophic cardiomyopathy with conventional management.

EPISODE 3 : AL and ATTR Diagnosis: Echo and Noncardiac Biopsy

A discussion on the subtle diagnosis of immunoglobulin light chain amyloidosis and transthyretin amyloidosis, with consideration for echocardiogram features and noncardiac biopsy.

EPISODE 4 : When Are Heart Biopsies Warranted?

Experts in the field of cardiac amyloidosis management discuss when heart biopsies are necessary and consider possible adverse events.

EPISODE 5 : Technetium Pyrophosphate Scan Benefits

The benefits of using technetium pyrophosphate scans to diagnose cardiac amyloidosis and the prevalence of transthyretin amyloidosis.

EPISODE 6 : Monoclonal Protein Testing and Wild-Type ATTR

The importance of lab testing for monoclonal proteins to interpret the results of technetium pyrophosphate scans and the significance of wild-type transthyretin amyloidosis.

EPISODE 7 : Technetium Pyrophosphate Scan Prior to TAVR

The significance of technetium pyrophosphate scans and wild-type disease when considering TAVR.

EPISODE 8 : AL and ATTR Survival Metrics

A strategy for prognosticating patients with immunoglobulin light chain amyloidosis and transthyretin amyloidosis.

EPISODE 9 : Poor Toleration: AL and ATTR Treatment Modification

Key opinion leaders discuss modifying treatment plans for patients with immunoglobulin light-chain amyloidosis and transthyretin amyloidosis who poorly tolerate initial therapy.

EPISODE 10 : Cardioversion and Atrial Fibrillation Ablation

A discussion on the effectiveness of cardioversion or atrial fibrillation ablation to control heart rhythm in patients with cardiac amyloidosis.

EPISODE 11 : Cardiac Amyloidosis: Pacemakers and Defibrillators

When to use pacemakers and defibrillators for patients with cardiac amyloidosis disease subtypes.

EPISODE 12 : Therapy Selection for Congestive Heart Failure

A discussion on decision factors for selecting therapy to manage congestive heart failure and an overview of available agents.

EPISODE 13 : Available ATTR Selective Stabilizers

Key opinion leaders provide an overview of available selective stabilizers for transthyretin amyloidosis.

EPISODE 14 : Cardiomyopathy Management: NSAID Options

Key opinion leaders consider the use of nonsteroidal anti-inflammatory drugs to treat cardiomyopathy.